The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Abstract

The rising rates of suicide warrant effective treatments that can quickly help stabilize suicidal individuals and prevent future suicidal crises from occurring. Across the past few decades, there has been a rise in the development of ultra-brief (1–4 sessions) and brief suicide-specific interventions (6–12 sessions) to meet this need. This article reviews several prominent ultra-brief and brief interventions, including the Teachable Moment Brief Intervention, Attempted Suicide Short Intervention Program, Safety Planning Intervention, Crisis Response Planning, Cognitive Therapy for Suicide Prevention, Brief Cognitive-Behavioral Therapy for Suicide Prevention, Collaborative Assessment and Management of Suicidality, and the Coping Long-Term With Active Suicide Program. A brief review of each interventions’ evidence base is also provided. Current challenges and directions for future research in testing the efficacy and effectiveness of suicide prevention initiatives are discussed.

In response to the exponential increase in suicide deaths during the past 2 decades (1), recent suicide prevention efforts have highlighted the importance of going beyond population-based screening and risk assessment to identify those at risk. Although recognition of those at risk is a crucial first step, effective interventions for treating suicide risk must be available as the next step in a comprehensive suicide prevention approach (2).

Treating depression was once considered the main strategy for reducing suicide risk, with usual care consisting of treatment of depression and other symptoms on the basis of diagnosis (3). However, it has become clear that depression, although a prominent risk factor for many at risk for suicide, is only one of numerous risks (4). Furthermore, research (5) has shown that suicidal thoughts and behavior are transdiagnostic symptoms. Therefore, although treating underlying conditions remains necessary, the approach is no longer thought to be sufficient. Preventing suicide has shifted to directly targeting suicidal ideation and behavior. In line with this understanding, a number of suicide-specific interventions have been developed and evaluated for their effectiveness and efficacy in reducing suicidal ideation and behavior. Suicide-specific treatments have certain elements in common that distinguish them from treatment as usual—namely, explicit focus on suicidal ideation and behavior, encouragement of individuals in developing internal coping strategies for safety and self-management (rather than reliance on external sources, such as hospitalization), and shared responsibility and collaboration for an individual’s safety, rather than sole clinician responsibility (6).

Suicide-specific interventions focus on one of two timeframes: ultra-brief interventions to be used while a suicidal crisis is occurring, and brief interventions used to help suicidal individuals develop skills and strategies to prevent suicidal crises from occurring. The suicide risk curve (Figure 1) demonstrates the time frames for crisis interventions versus interventions designed to prevent risk escalation.

FIGURE 1.

FIGURE 1. Suicide risk curve

Ultra-brief interventions are extremely brief (1–4 sessions) (7). Often, they are administered in close proximity to the suicidal crisis and conducted in a wide range of treatment and emergency settings, in comparison with nonsuicide-specific treatment as usual, which often involves ongoing long-term outpatient care (8). Brief interventions (6–12 sessions) are implemented typically following suicidal crises and may be combined with ultra-brief interventions (9).

In the past, the most widely used brief suicide-specific intervention was the “no-suicide contract,” in which clinicians asked clients to sign a document asserting their promise not to engage in suicidal behavior (10). However, beyond asking for a promise, the no-suicide contract failed to provide clients with strategies to avoid engaging in such behavior. Despite the anecdotal observation that no-suicide contracts may have helped to lower clinician anxiety regarding potential suicide risk, no empirical evidence supports the effectiveness of no-suicide contracts for preventing suicidal behavior (1013). Clients tend to view the no-suicide contract as a form of legal protection for clinicians and not as an intervention that helps them (10, 12). As such, this practice is no longer recommended.

This article reviews several prominent brief (6–12 sessions) and ultra-brief (1–4 sessions) suicide-specific interventions. Although not exhaustive, this review includes those interventions that target adult populations and for which there is some evidence base for effectiveness or efficacy.

Ultra-Brief Interventions

Ultra-brief interventions, such as the Teachable Moment Brief Intervention (TMBI) (14, 15), typically have several components (e.g., psychoeducation) to aid clients in understanding their condition and the treatments available to them and to enhance engagement in follow-up care (16). In narrative of suicidal crisis interventions, clients are asked to describe what led up to the suicidal event in order to help them understand the progression of their suicidal thoughts, feelings, and urges (17). Lethal means counseling aims to assess and reduce access to lethal means, such as firearms, poisons, and medications, during periods of increased suicide risk. Lethal means counseling may be paired with any of these other psychotherapies and can be lifesaving (18). Safety planning interventions are used to prevent escalation of suicidal crises and includes warning signs, coping strategies, social support, and emergency contacts (19, 20). Some versions of safety planning include lethal means counseling (19) whereas others do not (20). Ultra-brief suicide-specific interventions with some evidence base are presented in the next section.

Teachable Moment Brief Intervention (TMBI)

An innovative nonpsychotherapy approach, the TMBI, developed by Stephen O’Connor and colleagues (15), consists of nine components that take place during a one-time 30–60-minute interaction. This interaction takes place either on the medical-surgical unit or on a psychiatric inpatient unit within 2 days of a highly lethal suicide attempt. The idea is that engaging individuals while they are recovering from a medically lethal suicide attempt provides an opportunity to have them explore the motivations leading up to the attempt, as well as the aftereffects and consequences, and thereby identify proximal protective factors and increase motivation for future treatment toward suicide prevention.

Section 1 of TMBI begins as soon as the individual is medically stable (15). The clinician first approaches the individual on the medical-surgical unit and spends a few minutes building rapport and assessing the patient’s level of comfort in discussing the recent attempt. Second, the clinician makes a validating comment, such as how much pain the individual must have been in to try to take their own life. Third, the clinician explains that they would like to spend some time talking about the attempt, in order to understand the factors leading up to the attempt, to better clarify why it happened, and to inform steps for recovery.

In Section 2 of TMBI, the clinician expresses curiosity and encourages collaboration in trying to identify the drivers of the suicide attempt (15). This step leads to a discovery process as to how the client developed an orientation toward death. The clinician conducts a functional analysis to obtain as many details as possible regarding the function of the suicide attempt. The clinician then makes an inquiry into the individual’s perception of what was lost and what was gained by the attempt, nonjudgmentally raising the negative (i.e., medical and financial) consequences. The clinician also asks how the patient feels about having survived the attempt.

In Section 3 of TMBI, the clinician and patient collaborate on a short-term crisis response plan consisting of five coping strategies and provision of the crisis lifeline phone number (now 988 in the United States) (15). The next component consists of identifying major factors to be addressed in a suicide-specific treatment. The final component is to summarize what comes next in terms of treatment and in returning to life (work, family) outside the hospital.

A pilot randomized controlled trial (RCT) comparing 23 hospitalized individuals with a recent suicide attempt who received the TMBI versus 25 who received usual care (15) showed that, although the differences were not statistically significant, there was a trend toward increased treatment engagement among those receiving TMBI across a 12-month follow-up.

Attempted Suicide Short Intervention Program (ASSIP)

ASSIP is a brief, client-centered intervention designed to reduce suicide risk in 3–4 sessions, with the addition of contact letters sent across the next 2 years (17). As a brief intervention, ASSIP is not designed to be a stand-alone treatment, and the authors (21) noted that another long-term suicide-specific intervention should be used to supplement treatment. The therapeutic alliance, or collaborative relationship between the clinician and client, is a central component of ASSIP, and it is the foundation through which the clinician comes to understand the client’s suicidal experience and works with the client to reduce risk. ASSIP is based on action theory, narrative interviewing, cognitive-behavioral therapy (CBT), and attachment theory (21). Through this approach, clinicians view their clients as agents of goal-directed actions (e.g., suicide as a way to end their psychological pain) and use narrative interviewing to understand a recent suicidal crisis and to help strengthen the therapeutic relationship (21). These factors are thought to affect the client’s engagement in subsequent treatment sessions and the intervention’s utility.

Treatment begins by video recording clients telling their story of a recent suicidal crisis to describe “how they reached the point of wanting to kill themselves, and how they went about it” (17). In the next session, the clinician and client sit next to each other, as they watch the recording, to develop a deeper, shared understanding of the factors that led to the client’s suicide attempt. The clinician then provides the client with a psychoeducational handout on suicide. After the session is over, the clinician creates a draft case conceptualization. The third session consists of discussing the client’s feedback and questions on the psychoeducational handout, reviewing and revising the client’s case conceptualization, and writing down warning signs and safety strategies on a crisis card that is to be kept with the client at all times. During the next 2 years, semi-standardized letters, signed by the clinician, are sent to the client to reiterate the long-term risk of suicide and to remind the client about safety strategies. ASSIP was designed for adult populations, and to our knowledge, has not yet been adapted for or tested among youth populations.

Because ASSIP is a newer intervention, few trials have tested its efficacy. A 2016 RCT (22), conducted by the intervention’s developers, showed that participants treated with ASSIP had an 80% reduced risk of reattempting suicide and spent nearly 75% fewer days in the hospital across a 2-year follow-up, compared with those receiving treatment as usual. However, two later RCTs (23, 24) failed to replicate these results. Clients treated with ASSIP have tended to endorse higher ratings of the therapeutic alliance (22, 24, 25), treatment satisfaction (24), and satisfaction with therapeutic outcomes, which has been related to reduced suicidal ideation at 6-, 12-, and 24-months of follow-up (25). Secondary analysis of Gysin-Maillart et al.’s 2016 seminal work (22) has shown that ASSIP is more cost-effective than a single suicide risk assessment provided to control patients (26). Another examination of Gysin-Maillart et al.’s study showed that ASSIP was associated with more problem-focused coping, which has been inversely correlated with suicide ideation (27).

Safety Planning Intervention (SPI)

For many suicidal clients, an emergency or urgent care visit is the only occasion on which they receive services addressing their suicidal crisis and never receive follow-up care (2830). This lack of care is alarming because risk remains high for some time after a suicide crisis or attempt (30). Providing clients with useful strategies during the emergency visit to prevent further suicidal behavior may prevent return emergency visits and further suicidal behavior (31). The SPI incorporates theoretical concepts from Cognitive Therapy for Suicide Prevention, dialectical behavior therapy (DBT), and behavioral rehearsal strategies (e.g., stop, drop, and roll). The approach emphasizes planning ahead for the next crisis while the individual is not currently in crisis, identifying individual warning signs and distress tolerance strategies, encouraging individuals to reach out, as well as enhancing independent coping, help-seeking behaviors, and treatment engagement. The SPI is typically developed with clients after a risk assessment that, in part, determines their suitability for the intervention. Suitability is based on the client being able to identify a discrete suicidal crisis. The basic steps of the safety plan include the following: warning signs indicating an impending suicidal crisis; internal coping strategies (typically solo distracting or engrossing activities) for use to avert a crisis from escalating; social support and social settings as a means of distraction from suicidal thoughts; family members or friends who can help resolve the crisis; mental health professionals or agency contacts, hospital where emergency care can be received, and crisis-line contact information; and identification and reduction of access to potential use of lethal means.

The first five components are used when suicidal thoughts and other warning signs emerge. Reducing access to means is discussed after the rest of the safety plan has been completed, often with the aid of a family member or friend, for an agreed upon period of time. Clients are advised to follow the steps in order, if possible.

SPI has demonstrated efficacy and effectiveness as a stand-alone intervention and as part of multicomponent suicide-specific treatments across various settings and populations. The SPI, along with structured follow-up and monitoring, was tested in a large-scale cohort study (32) of 1,680 veterans attending one of five Veterans Affairs (VA) Emergency Departments (ED) for suicide-related concerns. The number of individuals presenting to any of the five intervention VA EDs with suicidal behavior was 45% lower in the 6 months after ED discharge compared with those presenting to a control site during the same time period (31, 33). Furthermore, clients who had received SPI had more than double the odds of attending at least one mental health treatment appointment in the 6 months following ED discharge, compared with those who did not receive SPI (31, 32).

Moreover, those who received SPI were significantly more likely to attend an outpatient mental health or substance abuse treatment appointment in the 3 months postdischarge compared with those who had not received SPI (33). The effect of SPI on treatment attendance and engagement is of particular importance, given the heightened risk of suicide following ED discharge (30).

Crisis Response Planning (CRP)

CRP is a brief intervention very similar to SPI, consisting of development of a crisis narrative and writing down on an index card, personalized warning signs, coping skills, social support contact information, and professional and crisis services (10). CRP has a growing body of research (34) supporting its effectiveness. An RCT (34) of 97 active-duty soldiers attending emergency behavioral health appointments showed that these soldiers were 76% less likely to attempt suicide during follow-up compared with those receiving treatment as usual.

Enhanced CRP (E-CRP) includes reasons for living and has been associated with a decreased likelihood of psychiatric hospitalization and greater increases in positive emotional states (calmness and hope) than standard CRP (S-CRP) (35). Furthermore, both E- and S-CRP have been associated with greater reductions in negative emotional states (depression, agitation or feeling on edge, urge to kill oneself, shame, and fatigue) than contracts for safety (35). Secondary analyses of clinical trial data (34) showed that more frequent use of E-CRP was associated with greater reduction in suicidal ideation and that this reduction was contingent on the participants’ ability to recall components of their CRP (20). CRP has also been incorporated into suicide-specific treatments, such as brief CBT for suicide prevention (36). An RCT (37) of active-duty soldiers at risk for suicide demonstrated that those who received brief CBT with CRP were 60% less likely to reattempt suicide during a 24-month follow-up than those who received treatment as usual.

Brief Suicide-Specific Interventions

Cognitive Therapy for Suicide Prevention (CT-SP)

CT-SP is a time-limited psychotherapy intervention that is based on Aaron Beck’s cognitive-behavioral model (38). According to this theory, an individual’s biopsychosocial vulnerabilities can interact with suicidal thoughts and behaviors to produce a “suicide mode” (38). CT-SP consists of an acute treatment phase consisting of approximately 10–12 structured weekly sessions, largely centered around the idea of applying CBT approaches to recognizing the suicide mode and knowing when one is in it and how to get out of it (39). This acute treatment includes an early phase of crisis management, an intermediate phase consisting largely of skills training, and a later phase that addresses relapse prevention (39). CT-SP also has a continuation phase, consisting of another six sessions provided across 12 weeks, as needed, after the acute treatment phase has been completed (39).

A typical CT-SP session is about 50 minutes long and is quite structured (38). The clinician and individual collaboratively set an agenda for the session, giving priority to suicidal ideation or to any life-threatening problems. The clinician conducts a mood and suicidal risk assessment, asks whether the safety plan has been used since the previous session, reviews homework, and focuses on new areas of cognitive restructuring and skills training.

During the first phase of the acute treatment protocol, which takes place across the first 2–3 sessions, the clinician conducts a thorough risk assessment and focuses on crisis management, which includes collaborative safety planning and means reduction counseling (40). The clinician obtains a detailed narrative timeline identifying the major situations, thoughts, and behaviors surrounding the most recent suicidal crisis, which is then used to generate a cognitive-behavioral case conceptualization to inform an individualized treatment plan. In addition, because hopelessness is often associated with increased suicidal risk, the first phase of CT-SP includes identifying reasons for living and developing hope kits that can remind individuals of their reasons for living, and the things they have hope for, when they are in a more suicidal mode of thinking.

In the intermediate phase, emphasis is placed on learning coping skills targeted to the particular risk factors, triggers, and cognitive-behavioral responses that were identified in the individual’s crisis narrative (41). These skills are based on evidence-based approaches, such as CBT and DBT, and include relaxation training, distraction, behavioral activation, self-care, and reduction of emotional vulnerability. Individuals are educated about the cognitive model and are taught how to restructure thoughts and beliefs that lead to the suicide mode and to modify dysfunctional core beliefs.

The later phase of CT-SP includes skills consolidation, relapse prevention, and treatment planning (42). The central relapse prevention exercise is a task in which the individual is guided to imagine how they might use the skills, cognitive restructuring, and safety planning learned in the earlier phases to prevent acting on suicidal thoughts (38). Once it is determined that the individual has consolidated the skills and can imagine using them and the safety plan, plans for further treatment, including a continuation phase of CT-SP, are considered.

In a well-powered RCT with an 18-month follow-up, Brown and colleagues (43) found that individuals in CT-SP treatment were 50% less likely to reattempt suicide compared with those in the usual care group. The researchers also found significant reductions in levels of depression and hopelessness in the CT-SP treatment group compared with the control group. Researchers of CT-SP are in the process of replicating these results in a community-based outpatient setting, with varied samples (including those with severe ideation but who have not attempted suicide) (44).

Brief Cognitive-Behavioral Therapy (BCBT) for Suicide Prevention

BCBT for Suicide Prevention, developed by Craig Bryan and M. David Rudd (36) as a next step in the development, refinement, and application of the cognitive-behavioral model to reduce suicidal behavior, is an adaptation of CT-SP. Similar to CT-SP, BCBT consists of three phases of treatment, spanning 12 sessions. Phase 1, session 1, of BCBT consists of orientation to the treatment, narrative risk assessment, and crisis management, including development of a crisis response plan and lethal means reduction counseling (36). Sessions 2–5 of phase 1 address treatment planning, skills for addressing sleep disturbance, mindfulness and relaxation, reasons for living and dying, and development of a survival kit. The primary tasks of phase 1 include describing the treatment, assessing the index suicidal episode, educating the client about the suicide mode, developing a crisis response plan, developing a treatment plan and obtaining the client’s commitment to the treatment, and providing training in emotion regulation skills.

Phase 2 (sessions 6–10) targets cognitive restructuring of suicidal belief systems, problem solving, and cultivation of cognitive flexibility (36). In this phase, the clinician teaches selected cognitive-behavioral skills by using ABC (antecedent, behavior, and consequence) worksheets, identifying patterns of problematic thinking, asking challenging questions, and teaching the use of coping cards and activity planning. The primary tasks of phase 2 are to review and rehearse emotion regulation strategies, in order to generalize use of these strategies across situations, and to target core beliefs and behaviors that contribute to the suicide mode. Phase 3 (sessions 11–12) is devoted to relapse prevention. The primary tasks of phase 3 are to conduct relapse prevention tasks repeatedly, to review the index suicidal episode several times until the individual demonstrates the ability to problem solve, and to develop hypothetical future crises and conduct imaginal exposure with the client imagining effective use of problem-solving skills. The treatment is more fully described in a book or treatment manual (36).

A number of studies have supported the effectiveness and efficacy of BCBT in reducing suicidal behavior. One RCT (37) found that, among active-duty U.S. Army soldiers who had either attempted suicide or experienced suicidal ideation with intent, those who were assigned to the BCBT condition were 60% less likely to attempt suicide in the 24 months between baseline and follow-up than those assigned to treatment as usual. In a secondary analysis of the same participant sample (6), three latent classes corresponding to low, moderate, and high suicide risk were identified, with classes significantly differing in terms of psychiatric symptom severity but not in demographic or historical variables. Rates of suicide attempts during the 2-year follow-up period significantly varied across these classes among those in the treatment-as-usual group, but did not vary across classes in the BCBT group, indicating that BCBT contributed to consistently low rates of suicidal behavior, despite psychiatric symptom severity (6).

Collaborative Assessment and Management of Suicidality (CAMS)

CAMS (45, 46) is a therapeutic framework that guides clinicians in assessing, tracking, and treating clients’ suicidal risk and typically takes 6–8 sessions. A core feature of CAMS is the collaborative and transparent way in which clinicians work with clients to comprehensively assess and safely manage suicide risk (45). Assessment and management of risk are guided by Suicide Status Forms (SSFs), which are used to assess multiple dimensions of suicide risk, track risk fluctuations over time, assist with planning treatment to target “drivers” of risk, and evaluate treatment outcomes (47). The SSF and CAMS are based on Shneidman’s cubic model of suicide (48), which posits that suicidal behavior and death result from “psychache” (i.e., psychological pain), perturbation, and stress. Other conceptual influences on the CAMS framework include Beck’s theory of hopelessness (49) and Baumeister’s view of self-hate as a driving factor of suicide (50). Jobes proposes that these factors are critical to assess and target in treatment (45).

In the first part of the SSF, clients are asked to rate their current experience of six dimensions of suicide risk and then to rank them in order of importance: psychological pain, stress, agitation, hopelessness, self-hate, and overall suicide risk (overall suicide risk is not ranked) (51). Clients then rate the extent to which their suicidal thoughts are related to themselves versus others, list and rank their reasons for living and for dying, rate how much they want to live versus how much they want to die, and indicate the “one thing that would help me no longer feel suicidal” (46). Later portions of the SSF include a treatment plan that the clinician and client codevelop, traditional suicide risk assessment items for the clinician to complete (e.g., frequency and duration of ideation, history of suicidal behaviors), and a stabilization plan—which is similar to a safety plan (19) or crisis response plan (10).

The CAMS approach calls for the clinician to physically sit next to the client while the two together complete the SSF. By sitting next to the client, the clinician is demystifying therapy; the client can see what is on the SSF and what the clinician is writing. This gesture of sitting next to the client is used in part to convey the message that the two are on the same team, and that the client’s input in treatment is encouraged and expected (46). Jobes notes that this arrangement differs from the traditional medical model, which approaches treatment in a more directive way, where the clinician is deemed to be the expert in suicide who knows what is best for the suicidal client. In that scenario, the client is directed to follow the clinician’s suggestions without much input, if any. The CAMS approach, on the other hand, recognizes that clients are experts in their own experience of suicidal risk and that it is the clinician’s job to develop a shared understanding of this perspective and to work with clients to address the risk in a way that is acceptable to both parties. Because CAMS is a flexible framework, it can be used with a range of interventions from varying theoretical backgrounds (e.g., cognitive-behavioral, psychodynamic, humanistic).

A growing number of studies have tested the efficacy and effectiveness of CAMS compared with treatment as usual (52, 53). CAMS has largely been tested among civilian adults in outpatient settings, although a few studies have been conducted in inpatient units or EDs (54, 55) or with active-duty military personnel (56, 57).

In adult populations, CAMS has demonstrated effectiveness in reducing suicidal ideation and overall symptom distress, compared with treatment as usual (53), but not in reducing suicidal behavior (52). These gains have been sustained for 12 months after treatment was completed in some studies (58), although not every trial has found this same effect (59). Participants in CAMS trials have also exhibited improvements in suicide ideation and distress from pre- to posttreatment (60) and quicker reduction in suicide ideation (in ∼6–8 sessions), compared with treatment as usual (56, 61). In addition, participants who have received CAMS have reported significant increases in hope (58), greater decreases in hopelessness (59, 62), and lower rates of ED visits (56). Furthermore, CAMS treatment has been associated with greater client satisfaction (58, 59), treatment retention (58, 59), and treatment acceptability and feasibility (54, 63).

In a trial comparing CAMS to DBT, however, CAMS was not superior on any outcome variable (e.g., suicide ideation, suicide attempt, nonsuicidal self-injury, hopelessness) among clients with borderline personality disorder who had recently attempted suicide (62). Furthermore, to our knowledge, no published RCT to date has demonstrated a significant effect of CAMS in reducing suicide attempts or self-harm. More research is needed to better understand the effect of CAMS on suicide-related behaviors.

The Coping Long-Term With Active Suicide Program (CLASP)

Ivan Miller and colleagues (64) have developed a brief suicide prevention intervention meant to reduce subsequent suicidal behavior during times of acute risk. The CLASP is an adjunctive intervention consisting of three individual in-person meetings, one meeting with the individual’s significant other or family, and 11 15–30-minute telephone contacts with the suicidal individual and his or her significant other or family member.

The CLASP intervention adapts strategies from Acceptance and Commitment Therapy (ACT) (65) and from Family Intervention-Telephone Tracking (FITT) (66) to reduce modifiable risk factors for suicide. Thus, the intervention aims to reduce hopelessness, bolster family and social support, teach problem-solving skills, and enhance treatment engagement. CLASP also focuses on identifying individual-specific risk factors.

During the initial meetings with the individual, a discussion informed by the ACT approach is begun to clarify the individual’s personal values toward facilitation of behavioral change (67). The focus on values leads to the setting of goals that are consistent with the individual’s beliefs. This approach is later extended to the meeting with the individual and their significant other or family member (SO) and results in an individualized life plan document that informs the telephone contacts.

Subsequent telephone contacts with the individual and their SO are modeled after the FITT intervention and are aimed at problem solving, including improvement of communication skills and monitoring of suicide risk (64). These telephone contacts also support problem-solving coping skills and enhanced treatment engagement by addressing any treatment barriers. The intervention is not considered to be psychotherapy—rather, the clinician is considered an advisor who takes a case-management type of approach.

In the first three sessions, the advisor meets with the individual, introduces the program, obtains a psychiatric history, evaluates current suicide risk status, develops or reviews a safety plan, begins a discussion of the individual’s values, and develops short-term treatment goals (64). This phase culminates in development of a life plan document that guides the telephone call component of the intervention. When the SO is included, in the fourth meeting, there is brief psychoeducation regarding suicide and suicide risk factors and a review of the life plan, which includes a safety plan.

Following these in-person meetings, the advisor conducts 11 15–30-minute telephone contacts with the suicidal individual and also with the SO separately (64). If no SO can be identified, the calls are conducted with the suicidal individual only. Frequency of these telephone contacts decreases across 6 months. The advisor monitors suicide risk, and when suicidality is present, the safety plan is reviewed. The advisor encourages problem solving and communication and discusses problems in terms of the identified values and the life plan document. Because CLASP is an adjunct treatment, when necessary, the advisor may contact the primary treatment provider.

In an initial open trial, CLASP was administered to 25 inpatients at risk for suicide (64). The in-person sessions were conducted on the unit, and the telephone calls were conducted during the 6 months postdischarge. CLASP was acceptable to about 75% of the clients, and most were able to identify a SO. Satisfaction with CLASP was high, and the 12% of clients who subsequently attempted suicide within the 6-month period represented a significantly lower number than previous subsequent suicide attempt rates among former inpatients. A pilot RCT (64) included an enhanced treatment-as-usual condition, called Safety Assessment and Follow-Up Evaluation (SAFE), which consisted of treatment as usual, plus enhanced monitoring of suicidal ideation and risk factors. Compared with control group participants, those receiving CLASP had lower rates of suicide attempts and hospitalizations during the 6-month follow-up. Thus, there is evidence for feasibility and acceptability of the CLASP intervention, as well as some promising pilot efficacy data.

Conclusions

Several brief and ultra-brief suicide prevention interventions have been developed during the last decade and have a promising evidence base. These interventions, especially the ultra-brief interventions, hold promise because they can be implemented in a wide range of clinical settings, with a minimum of staff training, compared with longer term treatments. Ultra-brief modalities have the advantage, because they can be delivered to an individual coming in for emergency treatment and they do not require ability or willingness of the patient to commit or adhere to a brief psychotherapy intervention consisting of 12 sessions across 6 months.

However, as is clear from this review, the evidence base for the acceptability, feasibility, and efficacy of most of these interventions is limited, and more remains to be known about which interventions work best for which individuals. Future research should aim to identify differences and similarities between the various interventions in terms of ease of implementation, barriers to implementation, acceptability to patients, indications for specific populations, and ultimate effectiveness and efficacy in reducing suicidal behavior.

Challenges to suicide prevention efficacy research include safety concerns regarding inclusion of individuals at risk, and the consequent historical exclusion of these individuals in clinical trials, as well as the low base rate of suicidal behavior, which limits the ability to measure the efficacy of suicide prevention interventions on this primary outcome measure (68). However, recent innovations in the development of safety protocols for inclusion of individuals at risk for suicide in clinical research (69) as well as dissemination of the National Action Alliance for Suicide Prevention (70) Zero Suicide framework (http://zerosuicide.sprc.org), provide enhanced opportunities for evaluating the effectiveness and efficacy of suicide prevention interventions and efforts. Further research is needed to determine acceptability and effectiveness of these interventions among diverse populations.

Department of Psychiatry, Columbia University Irving Medical Center, New York (all authors); Molecular Imaging and Neuropathology Division (Stanley) and Division of Behavioral Health Services and Policy Research (all authors), New York State Psychiatric Institute, New York.
Send correspondence to Dr. Monahan ().

The authors report no financial relationships with commercial interests.

References

1 Hedegaard H, Curtin SC, Warner M: Increase in suicide mortality in the United States, 1999–2018. NCHS Data Brief 2020; 362:1–8Google Scholar

2 Mann JJ, Michel CA, Auerbach RP: Improving suicide prevention through evidence-based strategies: a systematic review. Am J Psychiatry 2021; 178:611–624CrossrefGoogle Scholar

3 Bhar SS, Brown GK: Treatment of depression and suicide in older adults. Cogn Behav Pract 2012; 19:116–125CrossrefGoogle Scholar

4 Franklin JC, Ribeiro JD, Fox KR, et al.: Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychol Bull 2017; 143:187–232CrossrefGoogle Scholar

5 Oquendo MA, Baca-Garcia E: Suicidal behavior disorder as a diagnostic entity in the DSM-5 classification system: advantages outweigh limitations. World Psychiatry 2014; 13:128–130CrossrefGoogle Scholar

6 Bryan CJ, Peterson AL, Rudd MD: Differential effects of brief CBT versus treatment as usual on posttreatment suicide attempts among groups of suicidal patients. Psychiatr Serv 2018; 69:703–709CrossrefGoogle Scholar

7 Otto MW, Tolin DF, Nations KR, et al.: Five sessions and counting: considering ultra‐brief treatment for panic disorder. Depress Anxiety 2012; 29:465–470CrossrefGoogle Scholar

8 Haruvi Catalan L, Levis Frenk M, Adini Spigelman E, et al.: Ultra-brief crisis IPT-A based intervention for suicidal children and adolescents (IPT-A-SCI) pilot study results. Front Psychiatry 2020; 11:553422CrossrefGoogle Scholar

9 Diefenbach GJ, Rudd MD, Merling LF, et al.: Brief cognitive-behavioral therapy for suicidal inpatients. Cogn Behav Prac 2021; 28:224–240CrossrefGoogle Scholar

10 Rudd MD, Mandrusiak M, Joiner TE: The case against no‐suicide contracts: the commitment to treatment statement as a practice alternative. J Clin Psychol 2006; 62:243–251CrossrefGoogle Scholar

11 Kelly KT, Knudson MP: Are no-suicide contracts effective in preventing suicide in suicidal patients seen by primary care physicians? Arch Fam Med 2000; 9:1119–1121CrossrefGoogle Scholar

12 Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 2001; 40:24S–51SCrossrefGoogle Scholar

13 Stanford EJ, Goetz RR, Bloom JD: The No Harm Contract in the emergency assessment of suicidal risk. J Clin Psychiatry 1994; 55:344–348Google Scholar

14 O’Connor SS, Comtois KA, Wang J, et al.: The development and implementation of a brief intervention for medically admitted suicide attempt survivors. Gen Hosp Psychiatry 2015; 37:427–433CrossrefGoogle Scholar

15 O’Connor SS, Mcclay MM, Choudhry S, et al.: Pilot randomized clinical trial of the Teachable Moment Brief Intervention for hospitalized suicide attempt survivors. Gen Hosp Psychiatry 2020; 63:111–118CrossrefGoogle Scholar

16 Rotheram-Borus MJ, Piacentini J, Cantwell C, et al.: The 18-month impact of an emergency room intervention for adolescent female suicide attempters. J Consult Clin Psychol 2000; 68:1081–1093CrossrefGoogle Scholar

17 Michel K, Valach L, Gysin-Maillart A: A novel therapy for people who attempt suicide and why we need new models of suicide. Int J Environ Res Public Health 2017; 14:243CrossrefGoogle Scholar

18 Sale E, Hendricks M, Weil V, et al.: Counseling on Access to Lethal Means (CALM): an evaluation of a suicide prevention means restriction training program for mental health providers. Community Ment Health J 2018; 54:293–301CrossrefGoogle Scholar

19 Stanley B, Brown GK: Safety Planning Intervention: a brief intervention to mitigate suicide risk. Cogn Behav Prac 2012; 19:256–264CrossrefGoogle Scholar

20 Bryan CJ, May AM, Rozek DC, et al.: Use of crisis management interventions among suicidal patients: results of a randomized controlled trial. Depress Anxiety 2018; 35:619–628CrossrefGoogle Scholar

21 Michel K, Gysin-Maillart A: ASSIP—Attempted Suicide Short Intervention Program: A Manual for Clinicians. Newburyport, MA, Hogrefe Publishing, 2015CrossrefGoogle Scholar

22 Gysin-Maillart A, Schwab S, Soravia L, et al.: A novel brief therapy for patients who attempt suicide: a 24-months follow-up randomized controlled study of the Attempted Suicide Short Intervention Program (ASSIP). PLoS Med 2016; 13:e1001968Google Scholar

23 Arvilommi P, Valkonen J, Lindholm LH, et al.: A randomized clinical trial of Attempted Suicide Short Intervention Program versus crisis counseling in preventing repeat suicide attempts: a two-year follow-up study. Psychother Psychosom 2022; 91:190–199CrossrefGoogle Scholar

24 Conner KR, Kearns JC, Esposito EC, et al.: Pilot RCT of the Attempted Suicide Short Intervention Program (ASSIP) adapted for rapid delivery during hospitalization to adult suicide attempt patients with substance use problems. Gen Hosp Psychiatry 2021; 72:66–72CrossrefGoogle Scholar

25 Ring M, Gysin-Maillart A: Patients’ satisfaction with the therapeutic relationship and therapeutic outcome is related to suicidal ideation in the Attempted Suicide Short Intervention Program (ASSIP). Crisis 2020; 41:337–343CrossrefGoogle Scholar

26 Park AL, Gysin-Maillart A, Müller TJ, et al.: Cost-effectiveness of a brief structured intervention program aimed at preventing repeat suicide attempts among those who previously attempted suicide: a secondary analysis of the ASSIP randomized clinical trial. JAMA Netw Open 2018; 1:e183680CrossrefGoogle Scholar

27 Gysin-Maillart A, Soravia L, Schwab S: Attempted Suicide Short Intervention Program influences coping among patients with a history of attempted suicide. J Affect Disord 2020; 264:393–399CrossrefGoogle Scholar

28 Lizardi D, Stanley B: Treatment engagement: a neglected aspect in the psychiatric care of suicidal patients. Psychiatr Serv 2010; 61:1183–1191CrossrefGoogle Scholar

29 Kurz A, Möller HJ: Help-seeking behavior and compliance of suicidal patients. Psychiatr Prax 1984; 11:6–13Google Scholar

30 Monti K, Cedereke M, Öjehagen A: Treatment attendance and suicidal behavior 1 month and 3 months after a suicide attempt: a comparison between two samples. Arch Suicide Res 2003; 7:167–174CrossrefGoogle Scholar

31 Stanley B, Brown GK, Brenner LA, et al.: Comparison of the Safety Planning Intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry 2018; 75:894–900CrossrefGoogle Scholar

32 Knox KL, Stanley B, Currier GW, et al.: An emergency department-based brief intervention for veterans at risk for suicide (SAFE VET). Am J Public Health 2012; 102:S33–S37CrossrefGoogle Scholar

33 Stanley B, Brown GK, Currier GW, et al.: Brief intervention and follow-up for suicidal patients with repeat emergency department visits enhances treatment engagement. Am J Public Health 2015; 105:1570–1572CrossrefGoogle Scholar

34 Bryan CJ, Mintz J, Clemans TA, et al.: Effect of crisis response planning vs contracts for safety on suicide risk in US Army soldiers: a randomized clinical trial. J Affect Disord 2017; 212:64–72CrossrefGoogle Scholar

35 Bryan CJ, Mintz J, Clemans TA, et al.: Effect of crisis response planning on patient mood and clinician decision making: a clinical trial with suicidal US soldiers. Psychiatr Serv 2018; 69:108–111CrossrefGoogle Scholar

36 Bryan CJ, Rudd MD: Brief Cognitive-Behavioral Therapy for Suicide Prevention. New York, Guilford Publications, 2018Google Scholar

37 Rudd MD, Bryan CJ, Wertenberger EG, et al.: Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up. Am J Psychiatry 2015; 172:441–449CrossrefGoogle Scholar

38 Wenzel A, Brown GK, Beck AT: Cognitive Therapy for Suicidal Patients. Washington, DC, American Psychological Association, 2009CrossrefGoogle Scholar

39 Berk MS, Henriques GR, Warman DM, et al.: A cognitive therapy intervention for suicide attempters: an overview of the treatment and case examples. Cogn Behav Prac 2004; 11:265–277CrossrefGoogle Scholar

40 Henriques G, Beck AT, Brown GK: Cognitive therapy for adolescent and young adult suicide attempters. Am Behav Sci 2003; 46:1258–1268CrossrefGoogle Scholar

41 Wenzel A, Jager-Hyman S: Cognitive therapy for suicidal patients: current status. Behav Ther 2012; 35:121–130Google Scholar

42 Wenzel AA: Cognitive and behavioral therapy; in The American Psychiatric Association Publishing Textbook of Suicide Risk Assessment and Management. Edited by Gold LH, Frierson RL. Washington, DC, American Psychiatric Association, 2012Google Scholar

43 Brown GK, Ten Have T, Henriques GR, et al.: Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA 2005; 294:563–570CrossrefGoogle Scholar

44 Jobes DA, Au JS, Siegelman A: Psychological approaches to suicide treatment and prevention. Curr Treat Options Psychiatry 2015; 2:363–370CrossrefGoogle Scholar

45 Jobes DA: Managing Suicide Risk: A Collaborative Approach. New York, Guilford Press, 2006Google Scholar

46 Jobes DA: Managing Suicide Risk: A Collaborative Approach, 2nd ed. New York, Guilford Press, 2016Google Scholar

47 Jobes DA: The Collaborative Assessment and Management of Suicidality (CAMS): an evolving evidence‐based clinical approach to suicidal risk. Suicide Life Threat Behav 2012; 42:640–653CrossrefGoogle Scholar

48 Shneidman ES: Some reflections of a founder. Suicide Life Threat Behav 1988; 18:1–12CrossrefGoogle Scholar

49 Beck A: Cognitive Therapy of Depression. New York, Guilford Press, 1979Google Scholar

50 Baumeister RF: Suicide as escape from self. Psychol Rev 1990; 97:90–113CrossrefGoogle Scholar

51 Brausch AM, O’Connor SS, Powers JT, et al.: Validating the suicide status form for the Collaborative Assessment and Management of Suicidality in a psychiatric adolescent sample. Suicide Life Threat Behav 2020; 50:263–276CrossrefGoogle Scholar

52 Hanratty D, Kilicaslan J, Wilding H, et al.: A systematic review of efficacy of Collaborative Assessment and Management of Suicidality (CAMS) in managing suicide risk and deliberate self-harm in adult populations. Australas Psychiatry 2019; 27:559–564CrossrefGoogle Scholar

53 Swift JK, Trusty WT, Penix EA: The effectiveness of the Collaborative Assessment and Management of Suicidality (CAMS) compared to alternative treatment conditions: a meta‐analysis. Suicide Life Threat Behav 2021; 51:882–896CrossrefGoogle Scholar

54 Dimeff LA, Jobes DA, Koerner K, et al.: Using a tablet-based app to deliver evidence-based practices for suicidal patients in the emergency department: pilot randomized controlled trial. JMIR Ment Health 2021; 8:e23022CrossrefGoogle Scholar

55 Ellis TE, Rufino KA, Allen JG: A controlled comparison trial of the Collaborative Assessment and Management of Suicidality (CAMS) in an inpatient setting: outcomes at discharge and six-month follow-up. Psychiatry Res 2017; 249:252–260CrossrefGoogle Scholar

56 Jobes DA, Wong SA, Conrad AK, et al.: The Collaborative Assessment and Management of Suicidality versus treatment as usual: a retrospective study with suicidal outpatients. Suicide Life Threat Behav 2005; 35:483–497CrossrefGoogle Scholar

57 Jobes DA, Comtois KA, Gutierrez PM, et al.: A randomized controlled trial of the Collaborative Assessment and Management of Suicidality versus enhanced care as usual with suicidal soldiers. Psychiatry 2017; 80:339–356CrossrefGoogle Scholar

58 Comtois KA, Jobes DA, O’Connor SS, et al.: Collaborative Assessment and Management of Suicidality (CAMS): feasibility trial for next‐day appointment services. Depress Anxiety 2011; 28:963–972CrossrefGoogle Scholar

59 Ellis TE, Rufino KA, Allen JG, et al.: Impact of a suicide‐specific intervention within inpatient psychiatric care: the Collaborative Assessment and Management of Suicidality. Suicide Life Threat Behav 2015; 45:556–566CrossrefGoogle Scholar

60 Ryberg W, Zahl PH, Diep LM, et al.: Managing suicidality within specialized care: a randomized controlled trial. J Affect Disord 2019; 249:112–120CrossrefGoogle Scholar

61 Pistorello J, Jobes DA, Gallop R, et al.: A randomized controlled trial of the Collaborative Assessment and Management of Suicidality (CAMS) versus treatment as usual (TAU) for suicidal college students. Arch Suicide Res 2021; 25:765–789CrossrefGoogle Scholar

62 Andreasson K, Krogh J, Wenneberg C, et al.: Effectiveness of dialectical behavior therapy versus Collaborative Assessment and Management of Suicidality treatment for reduction of self‐harm in adults with borderline personality traits and disorder—a randomized observer‐blinded clinical trial. Depress Anxiety 2016; 33:520–530CrossrefGoogle Scholar

63 Comtois KA, Hendricks KE, DeCou CR, et al.: Reducing short term suicide risk after hospitalization: a randomized controlled trial of the Collaborative Assessment and Management of Suicidality. J Affect Disord 2023; 320:656–666CrossrefGoogle Scholar

64 Miller IW, Gaudiano BA, Weinstock LM: The coping long term with active suicide program: description and pilot data. Suicide Life Threat Behav 2016; 46:752–761CrossrefGoogle Scholar

65 Hayes SC, Strosahl KD, Wilson KG: Acceptance and Commitment Therapy. New York, Guilford Press, 1999Google Scholar

66 Bishop D, Miller I, Weiner D, et al.: Family Intervention: Telephone Tracking (FITT): a pilot stroke outcome study. Top Stroke Rehabil 2014; 21:S63–S74CrossrefGoogle Scholar

67 Miller I, Gaudiano B, Weinstock L: The Coping Long Term With Active Suicide Program (CLASP): A Multi-Modal Intervention for Suicide Prevention. New York, Oxford University Press, 2022CrossrefGoogle Scholar

68 Perlis RH: Hard outcomes: clinical trials to reduce suicide. Am J Psychiatry 2011; 168:1009–1011CrossrefGoogle Scholar

69 Ballard ED, Park LT, Pao M, et al.: Clinical trials with suicidal individuals can be conducted safely. J Clin Psychiatry 2020; 81:20l13353CrossrefGoogle Scholar

70 2012 National Strategy for Suicide Prevention: Goals and Objectives for Action. Washington, DC, US Department of Health and Human Services Office of the Surgeon General and National Action Alliance for Suicide Prevention, 2012Google Scholar